Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia

Published:2022-09 Issue: Volume:70 Page:116937
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Kang Ji-Bo,Chen Lu,Leng Xue-Jiao,Wang Jing-Jing,Cheng Yang,Wu Shi-Han,Ma Yi-Yuan,Yang Li-Jin,Cao Yu-Hao,Yang Xiao,Tong Zhen-Jiang,Wu Jia-Zhen,Wang Yi-Bo,Zhou Hai,Liu Jia-Chuan,Ding Ning,Dai Wei-Chen,Yu Yan-Cheng,Xue Xin,Sun Shan-Liang,Dai Xiao-Bin,Chang Liang,Wang Xiao-Long,Li Nian-Guang,Shi Zhi-Hao

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference38 articles.

1. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype;Falini;N Engl J Med,2005

2. The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond;Wander;Ther. Adv. Hematol.,2014

3. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia;Kumar;Genes Cancer,2011

4. Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia;Burnett;J Clin Oncol,2012

5. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment;Burnett;Cancer,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations;Journal of Medicinal Chemistry;2024-09-11

2. Targeting hematological malignancies with isoxazole derivatives;Drug Discovery Today;2024-08

3. Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review);Russian Journal of General Chemistry;2024-04

4. Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia;Bioorganic & Medicinal Chemistry;2024-02

5. Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia;Biomedicine & Pharmacotherapy;2023-12